Smiths Group PLC (NASDAQ:SMGZY) has received a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. Two investment analysts have rated the stock with a strong buy rating. Smiths Group PLC’s rating score has improved by 40.1% from three months ago as a result of a number of analysts’ ratings changes.

Analysts have set a 1 year consensus target price of $24.75 for the company, according to Zacks. Zacks has also assigned Smiths Group PLC an industry rank of 83 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research downgraded Smiths Group PLC from a “buy” rating to a “hold” rating in a research report on Saturday, March 18th.

Shares of Smiths Group PLC (NASDAQ:SMGZY) traded up 2.79% during mid-day trading on Wednesday, reaching $20.99. The company’s stock had a trading volume of 14,990 shares. The company has a 50 day moving average price of $21.31 and a 200 day moving average price of $19.70. Smiths Group PLC has a 12 month low of $14.14 and a 12 month high of $22.32. The stock has a market capitalization of $8.30 billion and a P/E ratio of 15.17.

WARNING: This news story was first posted by Financial Market News and is owned by of Financial Market News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.financial-market-news.com/2017/06/17/zacks-analysts-set-24-75-price-target-for-smiths-group-plc-smgzy.html.

About Smiths Group PLC

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.

Get a free copy of the Zacks research report on Smiths Group PLC (SMGZY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Smiths Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.